Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Renal Failure

  Free Subscription

Articles published in
Transplantation
    September 2017
  1. SCHMIDT BMW, Sugianto RI, Thurn D, Azukaitis K, et al
    Early effects of renal replacement therapy on cardiovascular comorbidity in children with end-stage kidney disease: findings from the 4C-T Study.
    Transplantation. 2017 Sep 18. doi: 10.1097/TP.0000000000001948.
    >> Share

  2. HO J, Schaub S, Wiebe C, Gao A, et al
    Urinary CXCL10 chemokine is associated with alloimmune and virus compartment-specific renal allograft inflammation.
    Transplantation. 2017 Sep 12. doi: 10.1097/TP.0000000000001931.
    >> Share

  3. SAWINSKI D, Lim MA, Cohen JC, Locke JE, et al
    Patient and Kidney Allograft Survival in Recipients with End Stage Renal Disease from Amyloidosis.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001930.
    >> Share

    August 2017
  4. LEVI C, Fremeaux-Bacchi V, Zuber J, Rabant M, et al
    Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence.
    Transplantation. 2017 Aug 25. doi: 10.1097/TP.0000000000001909.
    >> Share

    July 2017
  5. PETERS-SENGERS H, Heemskerk MBA, Geskus RB, Kers J, et al
    Validation of the Prognostic Kidney Donor Risk Index (KDRI) Scoring System of Deceased Donors for Renal Transplantation in the Netherlands.
    Transplantation. 2017 Jul 21. doi: 10.1097/TP.0000000000001889.
    >> Share

    June 2017
  6. FELTRAN LS, Varela P, Silva ED, Veronez CL, et al
    Targeted Next-generation Sequencing in Brazilian Children With Nephrotic Syndrome Submitted to Renal Transplant.
    Transplantation. 2017 Jun 28. doi: 10.1097/TP.0000000000001846.
    >> Share

  7. RAMESSUR CHANDRAN S, Han Y, Tesch GH, Di Paolo J, et al
    Inhibition of spleen tyrosine kinase reduces renal allograft injury in a rat model of acute antibody-mediated rejection in sensitized recipients.
    Transplantation. 2017 Jun 7. doi: 10.1097/TP.0000000000001826.
    >> Share

  8. CHHABRA AY, Leventhal J, Merchak AR, Ildstad S, et al
    HSCT Based Approaches for Tolerance Induction in Renal Transplant.
    Transplantation. 2017 Jun 1. doi: 10.1097/TP.0000000000001837.
    >> Share

  9. MOLNAR MZ, Nguyen DV, Chen Y, Ravel V, et al
    Predictive Score for Posttransplantation Outcomes.
    Transplantation. 2017;101:1353-1364.
    >> Share

    April 2017
  10. EGELAND EJ, Robertsen I, Hermann M, Midtvedt K, et al
    High tacrolimus clearance is a risk factor for acute rejection in the early phase after renal transplantation.
    Transplantation. 2017 Apr 27. doi: 10.1097/TP.0000000000001796.
    >> Share

  11. MARTIN MT, Koppe S
    Elbasvir/Grazoprevir Use in Postliver Transplantation Patients on Hemodialysis.
    Transplantation. 2017 Apr 3. doi: 10.1097/TP.0000000000001758.
    >> Share

  12. CHITTKA D, Hutchinson JA
    Pregnancy After Renal Transplantation.
    Transplantation. 2017;101:675-678.
    >> Share

  13. JAY CL, Washburn K, Dean PG, Helmick RA, et al
    Survival Benefit in Older Patients Associated With Earlier Transplant With High KDPI Kidneys.
    Transplantation. 2017;101:867-872.
    >> Share

    March 2017
  14. LAHAM G, Soler Pujol G, Vilches A, Cusumano A, et al
    Nonprogrammed vascular access is associated with greater mortality in patients who return to hemodialysis with a failing renal graft.
    Transplantation. 2017 Mar 28. doi: 10.1097/TP.0000000000001751.
    >> Share

  15. STEWART DE, Garcia VC, Rosendale JD, Klassen DK, et al
    Diagnosing the Decades-Long Rise in the Deceased Donor Kidney Discard Rate in the United States.
    Transplantation. 2017;101:575-587.
    >> Share

    February 2017
  16. VERNA EC, Brown RS Jr
    HCV Antiviral Therapy In Liver Transplant Candidates and Recipients with Renal Insufficiency.
    Transplantation. 2017 Feb 16. doi: 10.1097/TP.0000000000001688.
    >> Share

  17. ROBERTS V, Campbell DJ, Lu B, Chia J, et al
    The differential effect of apyrase treatment and hCD39 overexpression on chronic renal fibrosis following ischemia reperfusion injury.
    Transplantation. 2017 Feb 14. doi: 10.1097/TP.0000000000001679.
    >> Share

    January 2017
  18. MARTENS GR, Reyes LM, Butler JR, Ladowski JM, et al
    Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells from GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout Pigs.
    Transplantation. 2017 Jan 21. doi: 10.1097/TP.0000000000001646.
    >> Share

  19. PICCOLI GB, Cabiddu G, Attini R, Gerbino M, et al
    Outcomes of pregnancies after kidney transplantation: lessons learned from CKD. A comparison of transplanted, nontransplanted chronic kidney disease patients and low-risk pregnancies: a multicenter nationwide analysis.
    Transplantation. 2017 Jan 21. doi: 10.1097/TP.0000000000001645.
    >> Share

  20. YAZDANI S, Naesens M
    Foretelling Graft Outcome by Molecular Evaluation of Renal Allograft Biopsies: The GoCAR Study.
    Transplantation. 2017;101:5-7.
    >> Share

    December 2016
  21. WAISER J, Duerr M, Budde K, Rudolph B, et al
    Treatment of Acute Antibody-Mediated Renal Allograft Rejection with Cyclophosphamide.
    Transplantation. 2016 Dec 22. doi: 10.1097/TP.0000000000001617.
    >> Share

  22. LUBETZKY M, Chun S, Joelson A, Coco M, et al
    Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients with Directly Acting Antiviral Agents.
    Transplantation. 2016 Dec 22. doi: 10.1097/TP.0000000000001618.
    >> Share

  23. REKERS NV, Flaig TM, Mallat MJ, Spruyt-Gerritse MJ, et al
    Donor genotype and intragraft expression of CYP3A5 reflect the response to steroid treatment during acute renal allograft rejection.
    Transplantation. 2016.
    >> Share

  24. LONNING K, Midtvedt K, Leivestad T, Reisaeter AV, et al
    Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
    Transplantation. 2016;100:2705-2709.
    >> Share

  25. OSHIMA S, Karrer EE, Kawato Y, Maeda M, et al
    The Effect of ASP2409, a Novel CD86-Selective Variant of CTLA4-Ig, on Renal Allograft Rejection in Nonhuman Primates.
    Transplantation. 2016;100:2611-2620.
    >> Share

  26. SUTHERLAND AI
    Renal Transplantation in OCTOGENARIANS-A Real Proposition?
    Transplantation. 2016;100:2519-2520.
    >> Share

    October 2016
  27. DAVID-NETO E, Agena F, Ramos F, Triboni AH, et al
    Longitudinal Pharmacokinetics of Everolimus when Combined with Low-level of Tacrolimus in Elderly Renal Transplant Recipients.
    Transplantation. 2016.
    >> Share

  28. ZALTZMAN JS
    Is there a role for mTOR inhibitors in renal transplantation?
    Transplantation. 2016.
    >> Share

    September 2016
  29. BAMOULID J, Roodenburg A, Staeck O, Wu K, et al
    Clinical Outcome of Patients with De Novo C1q-Binding Donor-Specific HLA Antibodies after Renal Transplantation.
    Transplantation. 2016.
    >> Share


  30. Prevalence and Risk Factors of Noncontrolled and Resistant Arterial Hypertension in Renal Transplant Recipients: Erratum.
    Transplantation. 2016;100:e54.
    >> Share


  31. Antithymocyte Globulin is Associated With a Lower Incidence of De Novo Donor-Specific Antibodies in Moderately Sensitized Renal Transplant Recipients: Erratum.
    Transplantation. 2016;100:e54.
    >> Share

  32. HIRT-MINKOWSKI P, Rush DN, Gao A, Hopfer H, et al
    Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome.
    Transplantation. 2016;100:1988-96.
    >> Share

    August 2016
  33. PERRIN P, Kiener C, Javier RM, Braun L, et al
    Recent changes in chronic kidney disease-mineral and bone disorders (CKD-MBD) and associated fractures after kidney transplantation.
    Transplantation. 2016.
    >> Share

  34. KIM IK, Choi J, Vo AA, Kang A, et al
    Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients.
    Transplantation. 2016.
    >> Share

  35. CHOW KV, Flint SM, Shen A, Landgren A, et al
    Histological and Extended Clinical Outcomes Following ABO-incompatible Renal Transplantation Without Splenectomy or Rituximab.
    Transplantation. 2016.
    >> Share

  36. EISENBERGER U, Guberina H, Willuweit K, Bienholz A, et al
    Successful treatment of chronic hepatitis C virus infection with sofosbuvir and ledipasvir in renal transplant recipients.
    Transplantation. 2016.
    >> Share

  37. SOARES KC, Arend LJ, Lonze BE, Desai NM, et al
    Successful Renal Transplantation of Deceased Donor Kidneys With 100% Glomerular Fibrin Thrombi and Acute Renal Failure Due To Disseminated Intravascular Coagulation.
    Transplantation. 2016.
    >> Share

  38. BONANI M, Pereira RM, Misselwitz B, Fehr T, et al
    Chronic norovirus infection as a risk factor for secondary lactose maldigestion in renal transplant recipients: a prospective parallel cohort pilot study.
    Transplantation. 2016.
    >> Share

  39. DAVID-NETO E, Romano P, Triboni AH, Ramos F, et al
    Longitudinal Pharmacokinetics of Tacrolimus in Elderly Compared to Younger recipients in the first 6 months after renal transplantation.
    Transplantation. 2016.
    >> Share

  40. SUTHERLAND A
    Renal transplantation in Octogenarians - a real proposition?
    Transplantation. 2016.
    >> Share

  41. FREEMAN MA, Pleis JR, Bornemann K, Croswell E, et al
    Has the Department of Veterans Affairs found a way to avoid racial disparities in the evaluation process for kidney transplantation?
    Transplantation. 2016.
    >> Share

  42. KABORE R, Couchoud C, Macher MA, Salomon R, et al
    Age dependent risk of graft failure in young kidney transplant recipients.
    Transplantation. 2016.
    >> Share

    July 2016
  43. SEGALL L, Nistor I, Pascual J, Mucsi I, et al
    Criteria For And Appropriateness Of Renal Transplantation In Elderly Patients With End-Stage Renal Disease: A Literature Review And Position Statement On Behalf Of The European Renal Association-European Dialysis And Transplant Association Descartes W
    Transplantation. 2016.
    >> Share

  44. LONNING K, Midtvedt K, Leivestad T, Reisaeter AV, et al
    Are octogenarians with end stage renal disease candidates for renal transplantation?
    Transplantation. 2016.
    >> Share

  45. GOODRICH NP, Schaubel DE, Smith AR, Merion RM, et al
    National Assessment of Hospitalization Rates for Incident End Stage Renal Disease after Liver Transplantation.
    Transplantation. 2016.
    >> Share

  46. ELDER GJ
    Decreased circulating sclerostin levels in renal transplant recipients with persistent hyperparathyroidism; who's conducting the orchestra?
    Transplantation. 2016.
    >> Share

  47. SAWINSKI D, Lee DH, Doyle AM, Blumberg EA, et al
    Successful Posttransplant Treatment of Hepatitis C with Ledipasvir-Sofosbuvir in HIV+ Kidney Transplant Recipients.
    Transplantation. 2016.
    >> Share

  48. PEREZ-SAEZ MJ, Herrera S, Prieto-Alhambra D, Nogues X, et al
    Bone density, microarchitecture and tissue quality long-term after kidney transplant.
    Transplantation. 2016.
    >> Share

  49. SIMKINS J, Abbo LM, Camargo JF, Rosa R, et al
    Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates.
    Transplantation. 2016.
    >> Share

  50. EVENEPOEL P, Claes K, Viaene L, Bammens B, et al
    Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism.
    Transplantation. 2016.
    >> Share

    June 2016
  51. LOLLINGA WT, de Wit RH, Rahbar A, Vasse GF, et al
    Human Cytomegalovirus-Encoded Receptor US28 Is Expressed in Renal Allografts and Facilitates Viral Spreading In Vitro.
    Transplantation. 2016.
    >> Share

  52. CRESPO E, Roedder S, Sigdel T, Hsieh SC, et al
    Molecular and Functional Noninvasive Immune Monitoring in the ESCAPE Study for Prediction of Subclinical Renal Allograft Rejection.
    Transplantation. 2016.
    >> Share

  53. LINDAHL JP, Massey RJ, Hartmann A, Aakhus S, et al
    Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation.
    Transplantation. 2016.
    >> Share

    May 2016
  54. LIU S, Chaudhry MR, Berrebi AA, Papadimitriou JC, et al
    Polyomavirus Replication and Smoking Are Independent Risk Factors for Bladder Cancer After Renal Transplantation.
    Transplantation. 2016.
    >> Share

  55. HELLSTROM V, Lorant T, Dohler B, Tufveson G, et al
    High Posttransplant Cancer Incidence in Renal Transplanted Patients With Pretransplant Cancer.
    Transplantation. 2016.
    >> Share

    April 2016
  56. O'REGAN JA, Prendeville S, McCaughan JA, Traynor C, et al
    Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
    Transplantation. 2016.
    >> Share

  57. FRANK SJ, Walter WR, Latson L Jr, Cohen HW, et al
    New Dimensions in Renal Transplant Sonography: Applications of 3-Dimensional Ultrasound.
    Transplantation. 2016 Apr 21. doi: 10.1097/TP.0000000000001206.
    >> Share

  58. DE CARLIS L, Lauterio A, De Carlis R, Ferla F, et al
    Donation After Cardiac Death Liver Transplantation After More Than 20 Minutes of Circulatory Arrest and Normothermic Regional Perfusion.
    Transplantation. 2016;100:e21-2.
    >> Share

    March 2016
  59. DE LIMA JJ, Gowdak LH, de Paula FJ, Muela HC, et al
    Coronary Artery Disease Assessment and Intervention in Renal Transplant Patients: Analysis from the KiHeart Cohort.
    Transplantation. 2016.
    >> Share

  60. ALHAMAD T, Brennan DC, Brifkani Z, Xiao H, et al
    Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications after Kidney Transplantation.
    Transplantation. 2016.
    >> Share

  61. VISENTIN J, Ramaharo D, Ryman A, Contin-Bordes C, et al
    Prevalence of IgA Antibodies to beta2-Glycoprotein I: A Population-Dependent Feature?
    Transplantation. 2016;100:e13-4.
    >> Share

    February 2016
  62. WYLD ML, Chadban SJ
    Recurrent IgA Nephropathy After Kidney Transplantation.
    Transplantation. 2016.
    >> Share

  63. NEWMAN KL, Fedewa SA, Jacobson MH, Adams AB, et al
    Racial/Ethnic Differences in the Association Between Hospitalization and Kidney Transplantation Among Waitlisted End-Stage Renal Disease Patients.
    Transplantation. 2016.
    >> Share

  64. COZZI E, Biancone L, Lopez-Fraga M, Nanni-Costa A, et al
    Long-term Outcome of Living Kidney Donation: Position Paper of the European Committee on Organ Transplantation, Council of Europe.
    Transplantation. 2016;100:270-1.
    >> Share

  65. CANAUD G, Delville M, Legendre C
    Recurrence of Focal and Segmental Glomerulosclerosis After Transplantation.
    Transplantation. 2016;100:284-7.
    >> Share

  66. CLAYTON PA
    Risky Business-Is the RoCKeT Ready to fly?
    Transplantation. 2016;100:268-9.
    >> Share

    November 2015
  67. MOLNAR MZ, Ravel V, Streja E, Kovesdy CP, et al
    Racial Differences in Survival of Incident Home Hemodialysis and Kidney Transplant Patients.
    Transplantation. 2015.
    >> Share

  68. SHIN JI, Palta M, Djamali A, Kaufman DB, et al
    The Association Between Renin-Angiotensin System Blockade and Long-term Outcomes in Renal Transplant Recipients: The Wisconsin Allograft Recipient Database (WisARD).
    Transplantation. 2015.
    >> Share

    October 2015
  69. LAGING M, Kal-van Gestel JA, van de Wetering J, IJzermans JN, et al
    A High Comorbidity Score Should Not be a Contraindication for Kidney Transplantation.
    Transplantation. 2015.
    >> Share

    September 2015
  70. GATHOGO E, Harber M, Bhagani S, Levy J, et al
    Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
    Transplantation. 2015.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016